Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity

PURPOSE: It is well known that interferon-α (IFN-α), used for long time as the main therapy for HCV-related disease, induces thyroid alterations, but the impact of the new direct-acting antivirals (DAAs) on thyroid is not established. Aim of this prospective study was to evaluate if DAAs therapy may...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodia, R., Meloni, P. E., Mascia, C., Balestrieri, C., Ruggiero, V., Serra, G., Conti, M., Loi, M., Pes, F., Onali, S., Perra, A., Littera, R., Velluzzi, F., Mariotti, S., Chessa, L., Boi, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859881/
https://www.ncbi.nlm.nih.gov/pubmed/36048357
http://dx.doi.org/10.1007/s40618-022-01909-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859881/
https://www.ncbi.nlm.nih.gov/pubmed/36048357
http://dx.doi.org/10.1007/s40618-022-01909-0

Ejemplares similares